Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
("Mediclinic" or "the Company")
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.
25 July 2017
MEDICLINIC CEO ANNOUNCES PLANNED RETIREMENT
The Company announces that on 24 July 2017, Mr Danie Meintjes informed the Board of his intention to retire from his position as Chief Executive Officer and a director of the Company by 31 July 2018. The Nomination Committee will begin a search to identify a successor, to facilitate a smooth transition. Updates on this process will be announced when appropriate.
Mr Meintjes (aged 61) joined the group in 1985 as the Hospital Manager of Mediclinic Sandton. He became a member of Mediclinic International Limited's Executive Committee in 1995 and a director in 1996. Seconded to the company's operations in Dubai in 2006 and appointed as the Chief Executive Officer of Mediclinic Middle East in 2007, he was named Chief Executive Officer of Mediclinic International Limited in 2010. Following its combination with Al Noor Hospitals Group plc, Mr Meintjes became Chief Executive Officer of the enlarged group in February 2016.
Dr Edwin Hertzog, Chairman of Mediclinic, said: "Danie has been instrumental to the development of Mediclinic and the implementation of our strategy over 20 years of service to the group. We look forward to continuing to work with him over the coming twelve months and wish him well."
Mr Meintjes said: "It has been a great privilege to have been in a position to shape the success of Mediclinic. The Company is in a strong position and has excellent prospects for growth. I thank all my colleagues at Mediclinic for the part they play in meeting the challenges to our business and upholding the highest standards of clinical governance and ethical behaviour across our platforms."
About Mediclinic International plc
Mediclinic is an international private healthcare group with operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a LSE listed and UK-based private healthcare group.
Mediclinic comprises 74 hospitals and 37 clinics. Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 000 inpatient beds in total; Hirslanden operates 16 private acute care facilities and 4 clinics in Switzerland with more than 1 600 inpatient beds; and Mediclinic Middle East operates 6 hospitals and 31 clinics with more than 700 inpatient beds in the United Arab Emirates.
During February 2016, the combination of the Company (previously named Al Noor Hospitals Group plc), with operations mainly in Abu Dhabi in the United Arab Emirates, and Mediclinic International Limited was completed. Mediclinic International Limited was a South African based international private healthcare group founded in 1983 and listed on the JSE, the South African stock exchange, since 1986, with operations in South Africa, Namibia, Switzerland and the United Arab Emirates (mainly in Dubai). The combination resulted in the renaming of the enlarged group to Mediclinic International plc.
Mediclinic has a primary listing on the Main Market of the LSE, with secondary listings on the JSE in South Africa and the NSX in Namibia.
For further information, please contact:
Capita Company Secretarial Services Limited
+44 (0)207 954 9600
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
+44 (0)20 3786 8181
Brett Pollard/Debbie Scott (UK)
+44 (0)20 3727 1000
Frank Ford (South Africa)
+27 (0)21 487 9000
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd